Welcome to BioMarin’s Investor Relations & Media Page
We’ve brought together a variety of information in one location to better assist you in your efforts to research and develop news articles and learn about our company.
BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.